A 2024 JAMA Network Open study finds that napping over 30 minutes daily may raise mortality risk in older adults, but experts urge caution in interpreting the findings. A new study links excessive nap...
Phase 1 data for BGE-102 demonstrates significant reductions in hsCRP and inflammatory biomarkers, positioning it as a potential best-in-class therapy for cardiovascular risk and age-related inflammat...
A Danish register-based study reveals flu vaccination reduces heart attack and stroke risk by curbing inflammation, offering a key strategy for aging populations and preventive health. Recent data sho...
Advanced coronary CT scans with machine learning now quantify plaque volume more accurately than LDL levels, enabling early intervention and personalized prevention for cardiovascular disease. New AI-...
New research identifies IRF7 as a critical driver of unstable atherosclerotic plaques, offering a potential therapeutic target to reduce cardiovascular events through innovative clinical trials and te...
Recent research indicates shingles vaccination may reduce inflammation and epigenetic aging in older adults, potentially lowering risks of dementia and cardiovascular diseases. Emerging evidence shows...
Recent studies link methylglyoxal to AGE formation, driving aortic stiffening via oxidative stress. Gly-Low supplements show promise in reducing AGE levels, offering new preventive strategies for hear...
A new study demonstrates that CAR regulatory T cells targeting oxidized LDL can cut atherosclerotic plaque by 70% in mice, offering a potential one-time therapy for cardiovascular disease prevention. ...
Recent research highlights how neutrophil extracellular traps (NETs) drive chronic inflammation and vascular aging, with NET inhibitors like DNase I and PAD4 antagonists showing potential in reducing ...
Excessive neutrophil extracellular traps (NETs) promote chronic inflammation and endothelial dysfunction, increasing risks for atherosclerosis and stroke, with recent research highlighting inhibitors ...
